Â鶹´«Ã½

-


PA50337: Managing long term conditions 2

Academic Year: 2018/9
Owning Department/School: Department of Pharmacy & Pharmacology
Credits: 6      [equivalent to 12 CATS credits]
Notional Study Hours: 120
Level: Masters UG & PG (FHEQ level 7)
Period:
Modular (no specific semester)
Assessment Summary: CW 80%, MC 20%, OT 0%
Assessment Detail:
  • Assessment Group A: Medicines Optimisation Tool (PhIF Bath ass't grp A) (CW 60%)
  • Assessment Group A: CARE Tool (PhIF Bath ass't grp A) (CW 20%)
  • Assessment Group A: pOSA (PhIF Bath ass't grp A) (MC 20%)
  • Assessment Group A: Workshop Attendance (PhIF Bath ass't grp A) (OT 0%)
  • Assessment Group B: Medicines Optimisation Tool (PhIF London ass't grp B) (CW 60%)
  • Assessment Group B: CARE Tool (PhIF London ass't grp B) (CW 20%)
  • Assessment Group B: pOSA (PhIF London ass't grp B) (MC 20%)
  • Assessment Group B: Workshop Attendance (PhIF London ass't grp B) (OT 0%)
  • Assessment Group C: Medicines Optimisation Tool (PhIF South ass't grp C) (CW 60%)
  • Assessment Group C: CARE Tool (PhIF South ass't grp C) (CW 20%)
  • Assessment Group C: pOSA (PhIF South ass't grp C) (MC 20%)
  • Assessment Group C: Workshop Attendance (PhIF South ass'g grp C) (OT 0%)
  • Assessment Group D: Medicines Optimisation Tool (Non-PhIF ass't grp D) (CW 60%)
  • Assessment Group D: CARE Tool (Non-PhIF ass'g grp D) (CW 20%)
  • Assessment Group D: pOSA (Non-PhIF ass't grp D) (MC 20%)
  • Assessment Group D: Workshop Attendance (Non-PhIF ass't grp D) (OT 0%)
Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Requisites: In taking this module you cannot take PA50186
Description: Aims:
To update underpinning knowledge of key long term conditions and therapeutics enabling pharmacists to support patients in the self-management of their conditions through optimising medicines use.

Learning Outcomes:
On successful completion of this unit students will be able to:
1. Critically evaluate the evidence base for the management of key long term conditions (LTCs), specifically ischaemic heart disease (IHD), acute coronary syndrome (ACS), myocardial infarction (STEMI and NSTEMI), secondary prevention of IHD, chronic heart failure, lipid modification in primary and secondary cardiovascular disease (CVD risk reduction), peripheral arterial disease (PAD) and depression associated with LTCs. (Intellectual skill) (Medicines Optimisation Tool [MOT], portfolio task)
2. Reflect on your role in reviewing medication and monitoring their safety and effectiveness in patients with the above conditions. (knowledge and understanding) (MOT, Clinical Activity Reflective Exercise [CARE], portfolio task)
3. Explain the pathophysiology, symptoms and patient monitoring factors in the above conditions. (MOT, portfolio task)
4. Apply good communication and patient centred consultation skills to enhance the patient experience. ( Formative Work Based Assessment [WBA] and MOT)
5. Apply relevant clinical tools and interpret investigations to analyse risk and monitor patients with the above conditions. (taught / facilitated)
6. Safely review medication and optimise medicines use in patients with the above conditions. (MOT)

Skills:

* Planning & organisation
* Basic clinical examination skills
* Consultation skills
* Study skills
* Handling information
* communication skills
* Working with others
* Problem solving
* Scientific and practical skills
* Improving learning and performance
* Reflective practice
* Information & communication technology

Content:
Ischaemic Heart Disease (IHD) - Angina
Myocardial infarction - STEMI & NSTEMI
Secondary prevention of IHD
Chronic heart failure
Lipid modification in primary & secondary cardiovascular disease
Peripheral arterial disease
Depression associated with LTCs.
Programme availability:

PA50337 is Optional on the following programmes:

Department of Pharmacy & Pharmacology

Notes:

  • This unit catalogue is applicable for the 2018/19 academic year only. Students continuing their studies into 2019/20 and beyond should not assume that this unit will be available in future years in the format displayed here for 2018/19.
  • Programmes and units are subject to change in accordance with normal University procedures.
  • Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.
  • Undergraduates: .
  • Postgraduates: .